MHealth and safe-abortion: Improving information about and access to safe misoprostol abortions in Indonesia
Methods: Between October, 2013 and January, 2014, fifteen in-depth interviews were conducted in collaboration with a safe-abortion hotline among Indonesian women ages 18 and older who had safely self-induced abortion using misoprostol. Interviews explored four areas of interest: 1) Information needs about safe-abortion including questions and/or concerns about misoprostol 3) Individual mobile phone access and use patterns, comfort and literacy with mobile technologies, and 4) Desirable features of a safe-abortion mHealth smartphone application. IRB approval was granted by the UCSF committee on human research.
Results: Preliminary results suggest that a smartphone application providing information about safe-abortion would be desirable for women in Indonesia. Suggested features include: instructions on protocol and administration of misoprostol for abortion, photographs and warnings about impostor misoprostol, reminders to take pills, information about normal side-effects, information about when to seek care, and geo-coded maps for local health facilities.
Discussion: Given the proliferation of smartphone use in Indonesia and elsewhere, there is great promise for mobile technology to empower women seeking safe-abortions with accurate information about, and improved access to, safe medical abortion.
Learning Areas:Planning of health education strategies, interventions, and programs
Social and behavioral sciences
Identify ways in which mobile technologies may bridge gaps in information and access to safe misoprostol and medication abortions, specifically in settings where abortion is legally restricted
Keyword(s): Abortion, International MCH
Qualified on the content I am responsible for because: I am an epidemiologist by training and am the principal investigator on the grant for which the data contained in this abstract were collected. I have over 9 years of experience working and designing studies in the field of reproductive health, safe abortion, and family planning.
Any relevant financial relationships? No
I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.